August 9, 2022

Peter Lake, the World’s Only Anonymous Singer-Songwriter, Releases New Single ACORNS, a Song He Wrote in Response to the Current Recession Fears and Economic Malaise

Says Lake, ‘As a musician, we have a job to document the signs of the times, rather than just release and promote songs for economic gain.’ Featuring guitar and banjo of Guns ‘n Roses member Richard Fortus, the song is now available globally.

ACORNS, By Peter Lake

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) — In his newly released single called ACORNS, Peter Lake attempts to give a voice to the sign of the times. Without forcing a judgment on a range of topics from the stock market to fossil fuels, Lake summarizes the range of topics that seem to define the times, and which he feels should be cataloged for our “collective memory.” Lake suggests that history is often forgotten, but music can be a special tool that helps us remember. Mr. Lake’s decision to release the song, merely weeks after two successive singles, reflects his desire to write about contemporary issues as they are happening, a practice he urges other musicians to follow.

Says Lake:

“ACORNS is all about how times change, and how this is neither good nor bad, but just the way of the world. I hear about recession and everything getting expensive. I don’t know if these things are true or lasting. I don’t even really know what recession means! But there is a vibe that things aren’t going well, and we need to get ready for something, and the song tries to get at the new vibe.”

Lake goes on, explaining celebrity culture has made music a means of becoming famous. Lake notes that a hundred years ago, it would be “crazy” to go into music for money. “I think music should return to what it was originally, songs that are stories and songs that are about history, current events and the human condition. And most importantly, songs that could be sung in communities and that stand apart from whoever wrote them.”

ACORNS is now available globally wherever music is streamed. To learn more about the music of Peter Lake, please visit his social media. @peterlakemusic

All inquiries can be directed to PL@peterlakesounds.com.

Artist Biography:

Peter Lake is a Canadian-born, New York City-based singer-songwriter who revels in anonymity. In an age where privacy is rare, Peter is convinced that his ability to create music is protected by his anonymity, and by working with unconventional partners in an attempt to avoid the constraints of traditional record deals, which often consider recorded music as a means to promote tours.

Peter is the first of a kind: an artist who will only do live concerts via a web-based platform, thereby freeing him to focus exclusively on writing and recording new, original music that crosses all genres. In the process, Peter has assembled one of the largest singer-songwriter catalogs in the industry. His musical influences include Neil Young, Max Martin, David Bowie, Motown, and Drake.

It’s no surprise that his songs are hard to place, often flying between (and combining) House beats, crunchy guitar riffs and “traditional chants and natural sounds.”

From what we learned in our conversations with the artist, humility does not come naturally. On the other hand, it’s hard to consider his views as arrogant, given the intense sincerity with which he describes his plans. When asked about his goal, he replied as follows:

“My goal is to wake up every day and make music, and one day through that process, write and perform what will later be seen as the greatest song in history, a song that will define humankind for centuries.”

Related Images

Image 1: ACORNS, By Peter Lake

Single Album Art

Image 2: Peter Lake

Peter Lake recording at Quad Studios in New York City.

This content was issued through the press release distribution service at Newswire.com.

Attachment

ACORNS, By Peter Lake

August 9, 2022

Vietnamese minority activist to appeal four-year sentence on Aug. 16

The People’s Court of Vietnam’s Dak Lak province will hold an appeal hearing on the case of local religious freedom activist Y Wo Nie (also known as Ama Quynh) on August 16.

The 52-year-old, from the Ede ethnic minority, was a deacon of the Evangelical Church of Vietnam. He was sentenced to four years in prison by the People’s Court of Cu Kuin district on May 20 this year.

Nie was charged with “abusing freedoms and democracy to infringe upon the interests of the state, the lawful rights and interests of organizations and individuals,” as stated in Clause 2, Article 331 of the Criminal Code.

He is alleged to have taken pictures of three handwritten human rights reports and sent them to international organizations and also met with U.S. diplomats.

Nie did not have a defense lawyer at his trial but in the upcoming appeal session, Nguyen Van Mieng will defend him.

Mieng wrote on his Facebook page that Dak Lak province’s Department of Information & Communication made the initial assessment on Y Wo Nie, despite Vietnam’s commitment to international conventions on human rights.

“Contacting him at the Dak Lak provincial Police Department’s Detention Center, he was always cheerful,” Mieng said. “He always prayed day and night for the peace of the Church and his family. He extended his thanks to all the diplomatic missions, organizations and individuals concerned with his case.”

The indictment against Nie states that he wrote three reports, took pictures and sent them via WhatsApp to a number of overseas organizations.

The first report was on the religious and human rights situation of the Ede ethnic people in the Central Highlands and the second concerned violations of the right to religious freedom, which he sent to the U.N. Human Rights Committee and the U.S. Commission on International Religious Freedom (USCIRF).

The third report was titled “On the situation of religious freedom in general and in particular for ethnic people in the Central Highlands.”

The indictment also shows that Nie met with representatives of Ho Chi Minh City’s U.S. Embassy and Consulate in Gia Lai province in June 2020.

Dak Lak-based human rights activist Vo Ngoc Luc, who monitored the original trial, told RFA:

“In my opinion, legally, all of these things are not wrong and do not violate the law. It is normal for some activists here to meet with consular offices.”

“As for taking human rights classes online, any form of learning is good. When people learn to know more about the law, that’s a good thing, not a crime.”

“As for the accusation of sending pictures, if the information is said to be distorted, there must be an evaluation to prove that they are fake images to slander and misrepresent. On the other hand, there was no conclusion and that proves the pictures he gave are real, all of which shows that he did nothing wrong.”

Talking about the upcoming appeal, Luc said that in political cases it is very rare to have sentences reduced. However, he said that if the verdict is upheld, it would adversely affect diplomatic relations between Vietnam and the United States.

RFA has emailed the U.S. Embassy in Hanoi and the USCIRF to request comment on the case but has yet to receive responses.

Nie was arrested in September 2021 and his actions were alleged to have “affected the political security situation, social order and safety, and the normal operation of state administrative agencies, and reduced the public’s confidence in the regime, and affected the image of the State of the Socialist Republic of Vietnam as well as the prestige of the Communist Party of Vietnam in international diplomatic relations.”

Nie was previously sentenced to nine years in prison for “undermining the unity policy,” a ruling often used to imprison religious freedom activists among the many ethnic minorities in Vietnam’s Central Highlands and northern mountainous areas.

Around two hundred thousand Ede Montagnard live in the Central Highlands, according to the non-profit organization The Peoples of the World Foundation, living mainly in Dak Lak province. Most Ede are Protestant Christians. Montagnard is a collective term for the ethnic minorities living in the mountainous region.

A recent report on religious freedom from the USCIRF criticized the Vietnamese government’s crackdown on Montagnard religious groups in the Central Highlands.

August 9, 2022

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

REGULATED INFORMATION

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

DREAM enrollment complete, 12-month clinical data expected in fall of 2023

Mont-Saint-Guibert, Belgium – August 8, 2022, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the second quarter and first half of 2022.

Second Quarter 2022 Financial and Operating Highlights

Completed enrollment in DREAM U.S. pivotal trial; expect 12-month clinical data in the fall of 2023 and regulatory approval in the first half of 2024
Generated revenue of €935,000 from the commercialization of Genio® in Europe, primarily in Germany, which represents growth of more than five times the amount achieved in the second quarter of 2021
Activated 11 new implanting sites in Germany during the second quarter, bringing the total to 26 as of June 30, 2022; expecting to have at least 35 active implanting sites by the end of 2022
Received FDA approval of IDE submission to commence the ACCCESS study to treat complete concentric collapse (CCC) patients in the U.S., with first patient implant expected in the fourth quarter of 2022
Received FDA approval of the next generation Genio® 2.1 system for use in the DREAM study and CE mark for use in commercial patients in Europe; this improves patient comfort and compliance with a new smartphone application and upgraded external activation chip, which leverages Nyxoah’s scalable platform to continuously enhance patient comfort and therapy efficacy without requiring a new implant
Partnered with Acurable to distribute the AcuPebble SA100 wearable home sleep test to OSA patients in Germany; launch is expected in the fourth quarter of 2022
Included in the newly formed Euronext Tech Leaders Index, which is composed of 100+ innovative and high-growth technology companies with greater than €1 trillion in aggregate market capitalization

“We made significant progress on all of our key strategic priorities this quarter, including activating 11 new commercial sites in Germany, completing enrollment in our DREAM trial, and receiving approval for our ACCCESS IDE,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “From a commercial standpoint, our second quarter performance showing 42% quarter-over-quarter growth strengthens our confidence that we will achieve market leadership status in Germany by the end of 2022.”

“As the only commercially available hypoglossal nerve stimulation (HGNS) therapy approved for the treatment of CCC patients, we are encouraged by the first strong results from patients who are six months post-implantation. These results, combined with no longer having to perform a drug-induced sleep endoscopy (DISE) procedure prior to implant, are driving physicians to recommend Genio for their CCC and non-CCC patients,” continued Mr. Taelman.

Mr. Taelman concluded, “In the meantime, we have already begun investing in our U.S. market access organization. As for our ACCCESS study, we expect to implant the first patients before year end.”

Second Quarter and First Half 2022 Results

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION – INTERIM CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2022 (in thousands)

	For the three months ended June 30		For the six months ended June 30
	2022	2021	2022	2021

Revenue	€ 935	€ 170	€ 1 595	€ 355
Cost of goods sold	(€ 334)	(€ 63)	(€ 623)	(€ 115)
Gross profit	€ 601	€ 107	€ 972	€ 240
Research and Development Expense	(€ 3 470)	(€ 2 398)	(€ 7 065)	(€ 5 492)
Selling, General and Administrative Expense	(€ 4 536)	(€ 3 913)	(€ 8 729)	(€ 6 279)
Other income/(expense)	€ 14	(€ 101)	€ 150	(€ 97)
Operating loss for the period	(€ 7 391)	(€ 6 305)	(€ 14 672)	(€ 11 628)
Financial income	€ 4 670	€ 39	€ 6 246	€ 43
Financial expense	(€ 2 162)	(€ 574)	(€ 2 950)	(€ 899)
Loss for the period before taxes	(€ 4 883)	(€ 6 840)	(€ 11 376)	(€ 12 484)
Income taxes	(€ 107)	(€ 99)	(€ 315)	(€ 124)
Loss for the period	(€ 4 990)	(€ 6 939)	(€ 11 691)	(€ 12 608)

Loss attributable to equity holders	(€ 4 990)	(€ 6 939)	(€ 11 691)	(€ 12 608)
Other comprehensive loss
Items that may be subsequently reclassified to profit or loss (net of tax)
Currency translation differences	(€ 12)	€ 262	(€ 114)	€ 192
Total comprehensive loss for the year, net of tax	(€ 5 002)	(€ 6 677)	(€ 11 805)	(€ 12 416)
Loss attributable to equity holders	(€ 5 002)	(€ 6 677)	(€ 11 805)	(€ 12 416)

Basic Loss Per Share (in EUR)	(€ 0,193)	(€ 0,314)	(€ 0,453)	(€ 0,570)
Diluted Loss Per Share (in EUR)	(€ 0,193)	(€ 0,314)	(€ 0,453)	(€ 0,570)

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION – INTERIM CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT JUNE 30, 2022 (in thousands)

	As at
	June 30 2022	December 31 2021
ASSETS
Non-current assets
Property, plant and equipment	€ 2 111	€ 2 020
Intangible assets	32 570	25 322
Right of use assets	3 410	3 218
Deferred tax asset	1 429	46
Other long-term receivables	180	164
	€ 39 700	€ 30 770
Current assets
Inventory	506	346
Trade receivables	957	226
Other receivables	1 548	2 286
Other current assets	852	1 693
Financial assets	47 717	−
Cash and cash equivalents	75 602	135 509
	€ 127 182	€ 140 060
Total assets	€ 166 882	€ 170 830

EQUITY AND LIABILITIES
Capital and reserves
Capital	4 438	4 427
Share premium	228 158	228 033
Share based payment reserve	4 411	3 127
Other comprehensive income	88	202
Retained loss	(98 850)	(87 167)
Total equity attributable to shareholders	€ 138 245	€ 148 622

LIABILITIES
Non-current liabilities
Financial debt	8 089	7 802
Lease liability	2 859	2 737
Pension liability	80	80
Provisions	44	12
Deferred tax liability	−	5
	€ 11 072	€ 10 636
Current liabilities
Financial debt	661	554
Lease liability	672	582
Trade payables	4 301	3 995
Current tax liability	4 391	2 808
Other payables	7 540	3 633
	€ 17 565	€ 11 572
Total liabilities	€ 28 637	€ 22 208
Total equity and liabilities	€ 166 882	€ 170 830

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL INFORMATION – INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS AS AT JUNE 30, 2022 (in thousands)

	For the six months ended June 30
	2022	2021
CASH FLOWS FROM OPERATING ACTIVITIES
Loss before tax for the year	€ (11 376)	€ (12 484)
Adjustments for
Finance income	(6 246)	(43)
Finance expenses	2 950	899
Depreciation and impairment of property, plant and equipment and right-of-use assets	536	377
Amortization of intangible assets	402	428
Share-based payment transaction expense	1 292	−
Increase/(Decrease) in provisions	32	−
Other non-cash items	37	11
Cash generated before changes in working capital	€ (12 373)	€ (10 812)
Changes in working capital
Decrease/(Increase) in inventory	(160)	(27)
(Increase)/Decrease in trade and other receivables	1 011	(3 463)
Increase/(Decrease) in trade and other payables	2 053	6 061
Cash generated from changes in operations	€ (9 469)	€ (8 241)
Income tax paid	( 254)	( 111)
Net cash used in operating activities	€ (9 723)	€ (8 352)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment	(302)	(795)
Capitalization of intangible assets	(7 650)	(3 726)
(Increase)/Decrease in financial assets – current	(44 032)	−
Net cash used in investing activities	€ (51 984)	€ (4 521)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of principal portion of lease liabilities	(317)	(236)
Repayment of other loan	(42)	(42)
Interests paid	(134)	(258)
Repayment of recoverable cash advance	−	(105)
Proceeds from issuance of shares, net of transaction costs	136	362
Other financial costs	(8)	(10)
Net cash generated from financing activities	€ (365)	€ (289)
Movement in cash and cash equivalents	€ (62 072)	€ (13 162)
Effect of exchange rates on cash and cash equivalents	2 165	33
Cash and cash equivalents at January 1	€ 135 509	€ 92 300
Cash and cash equivalents at June 30	€ 75 602	€ 79 171

Revenue

Revenue was €935,000 for the second quarter ending June 30, 2022, compared to €170,000 for the second quarter ending June 30, 2021. Revenue for the first half of 2022 was €1.6 million, compared to €355,000 for the first half of 2021. The increase in revenue was attributable to the Company’s commercialization of the Genio® system, primarily in Germany.

Cost of Goods Sold

Cost of goods sold was €334,000 for the three months ending June 30, 2022, representing a gross profit of €601,000, or gross margin of 64.3%. This compares to total cost of goods sold of €63,000 in the second quarter of 2021, for a gross profit of €107,000, or gross margin of 62.9%.

For the six months ending June 30, 2022, total cost of goods sold was €623,000, representing a gross profit of €972,000, or gross margin of 60.9%. This compares to total cost of goods sold of €115,000 in the first half of 2021, for a gross profit of €240,000, or gross margin of 67.6%.

Research and Development Expenses

Research and Development expenses were €3.5 million for the three months ending June 30, 2022, versus €2.4 million for the prior year period, reflecting the Company’s investments in the development of next generation versions of the Genio® system as well as ongoing clinical studies, most notably DREAM in the U.S.

For the six months ending June 30, 2022, Research and Development expenses were €7.1 million, versus €5.5 million for the first half of 2021.

Selling, General and Administrative Expenses

Selling, General and Administrative expenses rose to €4.5 million for the second quarter of 2022, up from €3.9 million in the second quarter of 2021. This was due primarily to increased commercial efforts in Germany and other European markets, as well as investments in Nyxoah’s corporate infrastructure. The Company expects to continue adding headcount across the organization ahead of the U.S. commercial launch.

For the six months ending June 30, 2022, Selling, General and Administrative expenses were €8.7 million, up from €6.3 million in the first half of 2021 due to increased commercial efforts in Germany and investments in Nyxoah’s corporate infrastructure.

Operating Loss

Total operating loss for the second quarter and first half of 2022 was €7.4 million and €14.7 million, respectively, versus €6.3 million and €11.6 million in the second quarter and first half of 2021, respectively. This was driven by the acceleration in the Company’s R&D spending, as well as ongoing commercial and clinical activities. Nyxoah realized a net loss of €5.0 million and €11.8 million for the second quarter and first half of 2022, respectively, compared to a net loss of €6.7 million and €12.4 million for the second quarter and first half of 2021, respectively.

Cash Position

As of June 30, 2022, cash and financial assets totaled €123.3 million, compared to €135.5 million on December 31, 2021. Total cash burn was approximately €2.0 million per month during the first half of 2022. Nyxoah expects monthly cash burn to increase in the second half of 2022 to account for the commencement of the ACCCESS IDE trial in the U.S., and the current cash position provides ample liquidity to get to U.S. commercialization in 2024.

First Half 2022 Report

Nyxoah’s financial report for the first half of 2022, including details of the audited consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

Conference call and webcast presentation
Nyxoah will conduct a conference call open to the public today at 10:30 p.m. CET / 4:30 p.m. ET, which will also be webcast. To participate in the conference call, please access the following link to register for a dial-in number: https://register.vevent.com/register/BIfc3a52c9352e4e42958e9d816245b3b9

A question-and-answer session will follow the presentation of the results. To access the live webcast, go to https://investors.nyxoah.com/events. The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2021, filed with the Securities and Exchange Commission (“SEC”) on March 24, 2022, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com

+1 917 749 14

Attachment

ENGLISH_Q2 2022 Earnings PR Draft Final

August 9, 2022

APPEAL FOR INFORMATION – MR LOH TENG HIANG

The Police are appealing for information on the whereabouts of 66-year-old Mr Loh Teng Hiang. He was last seen at the vicinity of Blk 548 Serangoon North Avenue 3 on 7 August 2022.

Anyone with information is requested to call the Police Hotline at 1800-255-0000 or submit information online at www.police.gov.sg/iwitness. All information will be kept strictly confidential.

Source: Singapore Police Force

August 9, 2022

A reception to celebrate the 75th Anniversary of the Establishment of the Diplomatic Relations between Thailand and India

On 1 August 2022, the Royal Thai Embassy in New Delhi organised a reception to celebrate the 75th Anniversary of the Establishment of the Diplomatic Relations between Thailand and India under the theme “The 75th Anniversary: Celebrating Indo-Thai Friendship” at The Oberoi, New Delhi. H.E. Dr. Rajkumar Ranjan Singh, Minister of State for External Affairs, graced the reception as the Chief Guest along with participants such as foreign dignitaries, Indian high-level officials, members of Indian Private Sector, Thai community and media and bloggers.

At the reception, H.E. Miss Pattarat Hongtong, Ambassador of Thailand to India, and the Minister of State for External Affairs delivered their remarks reflecting the deep-rooted cultural ties between Thailand and India which have currently evolved into multifaceted dimensions i.e. political, security, trade, investment and tourism, and at all levels, bilateral, regional and multilateral. The reception has showcased vibrant images of Thailand such as cultural performances by the renowned Thai dance Sbun-nga troupe from Chiang Mai Province, Phad Thai cooking demonstration by Mr. Manosh Phuengprom, head chef from Market Café by Khao Restaurant, the Michelin starred restaurant in Bangkok, and his authentic Thai food served throughout the reception, and also the promotion of tourism, Thai food products, fresh vegetable and fruits imported from Thailand. This event is a great collaboration between the Royal Thai Embassy in New Delhi and key agencies namely, Tourism Authority of Thailand, Thai Trade Center in New Delhi, THAI Airways International, and Namdhari Thai fruit importer. In addition, the Oberoi hotel, in cooperation with the Royal Thai Embassy, also organised a Thai Food Week serving authentic Thai food by the same group of Thai chefs from 30 July – 7 August 2022.

Throughout 2022, the Royal Thai Embassy and Royal Thai Consulate-General in Kolkata, Mumbai and Chennai, as well as Team Thailand in India has organized and initiated plenty activities in promoting Thailand in India in various fields such as culture and economic in celebrating this 75th year of Indo-Thai relations.

Thailand established her diplomatic ties with India on 1 August 1947 or 75 years ago. However, both countries have historical and cultural roots dating back more than thousand years. Several cultural components support that, in fact, Thailand and India are much closer, especially in cultural and religious aspects. The people-to-people connectivity since then has complemented the stronger ties between the two countries which have evolved to become a strategic partnership at all levels. Since the beginning of this year, exchanges of visits between both sides in all key areas have resumed after the recovery of COVID-19 pandemic, in particular the 6th Foreign Office Consultations (FOC) on 21 April 2022 in New Delhi which will be followed by the 9th Thailand-India Joint Commission for Bilateral Meeting (JC) to be held on 17 August 2022 in Bangkok.

Source: Ministry of Foreign Affairs, Kingdom of Thailand

August 9, 2022

The Royal Thai Embassy in Oslo organized a community volunteering activity at Wat Pah Bodhibhumivana on the auspicious occasion of Her Majesty Queen Sirikit the Queen Mother’s 90th Birthday Anniversary 12 August 2022 and Mother’s Day of Thailand

On the auspicious occasion of Her Majesty Queen Sirikit the Queen Mother’s 90th Birthday Anniversary 12 August 2022 and Mother’s Day of Thailand, the Royal Thai Embassy in Oslo together with Wat Pah Bodhibhumivana (Lillehammer Buddhist Monastery) organized a community volunteering activity at Wat Pah Bodhibhumivana, Lillehammer, on 6 August 2022. This community volunteering activity is held in carrying out His Majesty King Maha Vajiralongkorn Phra Vajiraklaochaoyuhua’s wishes and initiatives to continue, preserve, and build upon His Majesty King Bhumibol Adulyadej the Great’s legacy by doing “good deeds from our hearts”.

H.E. Ms. Vimolbajra Ruksakiati, Ambassador of Thailand to Norway, the Embassy’s officials, together with Thai community with their Norwegian family of more than 40 peoples joined hands in this volunteering activity.

This volunteering activity is a part of the meditation hall’s construction project and the maintenance of the temple’s beautiful natural landscape. The construction of the meditation hall is scheduled to begin this fall and is expected to be completed in 2024. Those who wish to contribute to the construction of the meditation hall please see the temple’s website at https://www.facebook.com/groups/694736780915629/permalink/1977084749347486.

Source: Ministry of Foreign Affairs, Kingdom of Thailand